Transformation of MedTech: Which Investments Will Boost the Growth Potential of Medical Technology?
AI integration and medical devices miniaturization to drive transformational growth
Overview
Before the COVID-19 pandemic, medical technology (MedTech) registered significant investments in R&D. Top MedTech companies invest about 7% to 8% of their total revenues toward the R&D of novel products or to enhance existing products. The key sources for MedTech R&D investments are corporate budgets, venture capital and private equity firms, government grants, public funding, and partnerships and collaborations.
What are the key technological megatrends for MedTech R&D investment for cardiology and neurology?
What are the key R&D investment activities in cardiology and neurology? What are the key merger and acquisition (M&A) activities in cardiology and neurology?
What are the key growth opportunities for industry participants?
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.
